American Heart Journal
Volume 156, Issue 2 , Pages 248-255 , August 2008

Spontaneous reperfusion in ST-elevation myocardial infarction: Comparison of angiographic and electrocardiographic assessments

  • Kevin R. Bainey, MD

      Affiliations

    • University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Yuling Fu, MD

      Affiliations

    • University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Galen S. Wagner, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Shaun G. Goodman, MD

      Affiliations

    • University of Toronto and the Canadian Heart Research Centre, Toronto, Ontario, Canada
    • ,
  • Allan Ross

      Affiliations

    • Washington, DC
    • ,
  • Christopher B. Granger, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Frans Van de Werf, MD

      Affiliations

    • University Hospital Gasthuisberg, Leuven, Belgium
    • ,
  • Paul W. Armstrong, MD

      Affiliations

    • University of Alberta, Edmonton, Alberta, Canada
    • Corresponding Author InformationReprint requests: Paul W. Armstrong, MD, Division of Cardiology, University of Alberta, 251 Medical Sciences Building Edmonton, Alberta Canada T6G 2H7.
    • ,
  • for the ASSENT 4 PCI Investigators

Received 21 January 2008 ,Accepted 12 March 2008.

References 

  1. De Wood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897–902
  2. Rimar D, Crystal E, Battler A, et al. Improved prognosis of patients presenting with clinical markers of spontaneous reperfusion during acute myocardial infarction. Heart. 2002;88:352–356
  3. Steg PG, Himbert D, Benamer H, et al. Conservative management of patients with acute myocardial infarction and spontaneous acute patency of the infarct-related artery. Am Heart J. 1997;134:248–252
  4. Christian TF, Milavetz JJ, Miller TD, et al. Prevalence of spontaneous reperfusion and associated myocardial salvage in patients with acute myocardial infarction. Am Heart J. 1998;135:421–427
  5. Ross AM, Coyne KS, Reiner JS, et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. J Am Coll Cardiol. 1999;34:1954–1962
  6. Lee CW, Hong MK, Lee JH, et-al. Determinants and prognostic significance of spontaneous coronary recanalization in acute myocardial infarction. Am J Cardiol 2001;87:951-4, A953.
  7. Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001;104:636–641
  8. Terkelsen CJ, Norgaard BL, Lassen JF, et al. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-MONitoring in Acute Myocardial Infarction study (The MONAMI study). Eur Heart J. 2006;27:267–275
  9. Simes RJ, Topol EJ, Holmes DR, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation. 1995;91:1923–1928
  10. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) Investigators . Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with St-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet. 2006;367:569–578
  11. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) Investigators . Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 2001;358:605–613
  12. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators . Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial. Lancet. 1999;354:716–722
  13. Schroder R, Wegscheider K, Schroder K, et al. for the INJECT trial group Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol. 1995;26:1657–1664
  14. Purcell IF, Newall N, Farrer M. Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes. Heart. 1997;78:465–471
  15. Zijlstra F, Ernst N, de Boer MJ, et al. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol. 2002;39:1733–1737
  16. Hata K, Whittaker P, Kloner RA, et al. Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: role of adenosine. Circulation. 1998;97:692–702
  17. Margaglione M, Grandone E, Di Minno G. Plasma predictors of ischemic complications of atherosclerosis: open issues. Biomed Pharmacother. 1993;47:445–449
  18. Andrews J, Straznicky IT, French JK, et al. ST-segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. Circulation. 2000;101:2138–2143
  19. Roe MT, Ohman EM, Maas AC, et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol. 2001;37:9–18
  20. de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 2001;38:1283–1294
  21. Schroder K, Wegscheider K, Zeymer U, et al. Extent of ST-segment deviation in a single electrocardiogram lead 90 min after thrombolysis as a predictor of medium-term mortality in acute myocardial infarction. Lancet. 2001;358:1479–1486
  22. van't Hof AW, Liem A, de Boer M, et al. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet. 1997;350:615–619
  23. Lundergan CF, Reiner JS, McCarthy WF, et al. Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. J Am Coll Cardiol. 1998;32:641–647

PII: S0002-8703(08)00226-3

doi: 10.1016/j.ahj.2008.03.018

American Heart Journal
Volume 156, Issue 2 , Pages 248-255 , August 2008

Article Tools

* Image Usage & Resolution